» Articles » PMID: 34065783

Do Transgenerational Epigenetic Inheritance and Immune System Development Share Common Epigenetic Processes?

Overview
Journal J Dev Biol
Specialty Biology
Date 2021 Jun 2
PMID 34065783
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetic modifications regulate gene expression for development, immune response, disease, and other processes. A major role of epigenetics is to control the dynamics of chromatin structure, i.e., the condensed packaging of DNA around histone proteins in eukaryotic nuclei. Key epigenetic factors include enzymes for histone modifications and DNA methylation, non-coding RNAs, and prions. Epigenetic modifications are heritable but during embryonic development, most parental epigenetic marks are erased and reset. Interestingly, some epigenetic modifications, that may be resulting from immune response to stimuli, can escape remodeling and transmit to subsequent generations who are not exposed to those stimuli. This phenomenon is called transgenerational epigenetic inheritance if the epigenetic phenotype persists beyond the third generation in female germlines and second generation in male germlines. Although its primary function is likely immune response for survival, its role in the development and functioning of the immune system is not extensively explored, despite studies reporting transgenerational inheritance of stress-induced epigenetic modifications resulting in immune disorders. Hence, this review draws from studies on transgenerational epigenetic inheritance, immune system development and function, high-throughput epigenetics tools to study those phenomena, and relevant clinical trials, to focus on their significance and deeper understanding for future research, therapeutic developments, and various applications.

Citing Articles

Non-Coding RNAs and Innate Immune Responses in Cancer.

Diaz C, Hernandez-Huerta M, Perez-Campos Mayoral L, Villegas M, Zenteno E, Martinez Cruz M Biomedicines. 2024; 12(9).

PMID: 39335585 PMC: 11429077. DOI: 10.3390/biomedicines12092072.


Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer.

Zayeri Z, Parsi A, Shahrabi S, Kargar M, Davari N, Saki N Cancer Cell Int. 2023; 23(1):264.

PMID: 37936149 PMC: 10631091. DOI: 10.1186/s12935-023-03117-z.


Improving Dietary Zinc Bioavailability Using New Food Fortification Approaches: A Promising Tool to Boost Immunity in the Light of COVID-19.

Chemek M, Kadi A, Merenkova S, Potoroko I, Messaoudi I Biology (Basel). 2023; 12(4).

PMID: 37106716 PMC: 10136047. DOI: 10.3390/biology12040514.


New Insight into Molecular and Hormonal Connection in Andrology.

Francomano D, Sanguigni V, Capogrosso P, Deho F, Antonini G Int J Mol Sci. 2021; 22(21).

PMID: 34769341 PMC: 8584869. DOI: 10.3390/ijms222111908.


Entropy and Fractal Dimension Study of the TDP-43 Protein Low Complexity Domain Sequence in ALS Disease Severity and SARS-CoV-2 Gene Sequences in Virulence Variability.

Dehipawala S, Cheung E, Tremberger G, Cheung T Entropy (Basel). 2021; 23(8).

PMID: 34441178 PMC: 8393862. DOI: 10.3390/e23081038.

References
1.
Sanchez-Mut J, Graff J . Epigenetic Alterations in Alzheimer's Disease. Front Behav Neurosci. 2016; 9:347. PMC: 4681781. DOI: 10.3389/fnbeh.2015.00347. View

2.
Oamen H, Lau Y, Caudron F . Prion-like proteins as epigenetic devices of stress adaptation. Exp Cell Res. 2020; 396(1):112262. DOI: 10.1016/j.yexcr.2020.112262. View

3.
Popescu D, Botting R, Stephenson E, Green K, Webb S, Jardine L . Decoding human fetal liver haematopoiesis. Nature. 2019; 574(7778):365-371. PMC: 6861135. DOI: 10.1038/s41586-019-1652-y. View

4.
Morey C, Navarro P, Debrand E, Avner P, Rougeulle C, Clerc P . The region 3' to Xist mediates X chromosome counting and H3 Lys-4 dimethylation within the Xist gene. EMBO J. 2004; 23(3):594-604. PMC: 1271805. DOI: 10.1038/sj.emboj.7600071. View

5.
Ginhoux F, Guilliams M . Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity. 2016; 44(3):439-449. DOI: 10.1016/j.immuni.2016.02.024. View